Molecular Partners AG MOLN
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 0.00 | 787.30K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | 0.00 | 787.30K |
| Cost of Revenue | 44.87M | 45.68M | 46.89M | 47.41M | 49.56M |
| Gross Profit | -44.87M | -45.68M | -46.89M | -47.41M | -48.77M |
| SG&A Expenses | 20.25M | 20.06M | 19.65M | 20.13M | 20.72M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 65.12M | 65.74M | 66.54M | 67.54M | 70.28M |
| Operating Income | -65.12M | -65.74M | -66.54M | -67.54M | -69.49M |
| Income Before Tax | -64.56M | -72.12M | -74.01M | -70.97M | -75.14M |
| Income Tax Expenses | 5.00K | 5.00K | 2.80K | 100.00 | 100.00 |
| Earnings from Continuing Operations | -64.56 | -72.13 | -74.01 | -70.97 | -75.14 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -64.56M | -72.13M | -74.01M | -70.97M | -75.14M |
| EBIT | -65.12M | -65.74M | -66.54M | -67.54M | -69.49M |
| EBITDA | -62.93M | -63.49M | -64.32M | -65.31M | -67.24M |
| EPS Basic | -1.71 | -1.93 | -1.99 | -1.91 | -2.09 |
| Normalized Basic EPS | -1.07 | -1.15 | -1.19 | -1.14 | -1.25 |
| EPS Diluted | -1.71 | -1.93 | -1.99 | -1.91 | -2.09 |
| Normalized Diluted EPS | -1.07 | -1.15 | -1.19 | -1.14 | -1.25 |
| Average Basic Shares Outstanding | 150.62M | 149.71M | 149.08M | 148.55M | 144.34M |
| Average Diluted Shares Outstanding | 150.62M | 149.71M | 149.08M | 148.55M | 144.34M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |